Obermatt
See Similar Stocks →

Twist Bioscience

NSQ:TWST · US90184D1000
BiotechnologyMedium

360

46
Profit price90
Owner Earnings Yield1
Dividend Yield1
Price/Sales16
EV / Gross Profit34
Price/Book11
Return on Capital54
Cash Return on Capital53
Return on Equity60
EBIT Margin24
Gross Profitability61
Accruals57
Owner Earnings Margin46
Sales growth77
Profit growth61
Reinvestment9
Price momentum94
Debt load55
Refinancing63
Debt Payback1
Liquidity85
Analyst ratings78
Opinion Changes74
Price Target Upside1
Market mood15
Value Creation6/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Twist Bioscience doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryBiotechnology
SizeMedium
TypePublic Company
ExchangeNASDAQGS
Founded2013
Employees1,035
Websitetwistbioscience.com
ISINUS90184D1000
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Artificial IntelligenceGeneticsHealth DiagnosticsImmunologyInfectious DiseasesBio-based and Renewable MaterialsFarmingBiotechnologyChemicalHealth Care

Description

Twist Bioscience Corporation is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. In fields such as health care, food/agriculture, industrial chemicals/materials, and acad…

Analysis

Middle-of-the-road

Twist Bioscience Corporation is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is adequate. The company scores 6/20 on our value-creation score: not creating value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
87
2026

All-time high

87

Jun 2026

All-time low

52

Mar 2026

Average rank

70

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
16
—
—
—
Price/Earnings
86
—
—
—
Price/Book
11
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
14
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Twist Bioscience with its peers
Butterfly Network
NYQ:BFLY
23
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
GoDaddy
NYQ:GDDY
85
CountryUSA
IndustryIT Services
SizeLarge
Full Stock Analysis →
MongoDB
NMQ:MDB
28
CountryUSA
IndustryIT Services
SizeLarge
Full Stock Analysis →
Corteva
NYQ:CTVA
96
CountryUSA
IndustryChemicals
SizeX-Large
Full Stock Analysis →
SailPoint
NSQ:SAIL
40
CountryUSA
IndustrySoftware
SizeLarge
Full Stock Analysis →
GeneDx
NSQ:WGS
6
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →